Skin AGEs and diabetic neuropathy
Abstract Advanced glycation end-products (AGEs) are heterogeneous molecules produced by the non-enzymatic glycation of proteins, lipids, or nucleic acids during hyperglycaemia. Accumulation of AGEs in the peripheral nerves has recently been proposed as an additional risk factor for the development o...
Main Authors: | Stella Papachristou, Kalliopi Pafili, Nikolaos Papanas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-021-00697-7 |
Similar Items
-
Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis
by: Mahboobeh sadat Hosseini, MD, et al.
Published: (2021-12-01) -
Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study
by: Xian Wang, et al.
Published: (2021-04-01) -
Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus
by: Alexandra Filipov, et al.
Published: (2022-03-01) -
Role of Advanced Glycation End Products in Assessment of Diabetes Mellitus as a Risk Factor for Retinal Vein Occlusion
by: Karolina Kaźmierczak, et al.
Published: (2021-08-01) -
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures
by: Fadi Alkhami, et al.
Published: (2024-01-01)